Evaluation of 177Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective 177Lu-PSMA-617 and NOX66 Combination Trial (LuPIN).
Saved in:
| Title: | Evaluation of 177Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective 177Lu-PSMA-617 and NOX66 Combination Trial (LuPIN). |
|---|---|
| Authors: | Pathmanandavel, Sarennya1, Crumbaker, Megan2,3,4, Bao Ho1, Yam, Andrew O.2,3,4, Wilson, Peter5, Niman, Remy5, Ayers, Maria1, Sharma, Shikha1, Hickey, Adam1, Eu, Peter6, Stockler, Martin7, Martin, Andrew J.7, Joshua, Anthony M.2,3,4, Nguyen, Andrew1,4, Emmett, Louise1,3,4 louise.emmett@svha.org.au |
| Source: | Journal of Nuclear Medicine. Feb2023, Vol. 64 Issue 2, p221-226. 6p. |
| Database: | Engineering Source |
Be the first to leave a comment!
